The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
Open accessAbstract
Background Intensive treatment of multiple cardiovascular risk factors can halve mortality among people with established type 2 diabetes. We investigated the effect of early multifactorial treatment after diagnosis by screening.Methods In a pragmatic, cluster-randomised, parallel-group trial done in Denmark, the Netherlands, and the UK, 343 general practices were randomly assigned screening of registered patients aged 40-69 years without known diabetes followed by routine care of diabetes or screening followed by intensive treatment of multiple risk factors. The primary endpoint was first cardiovascular event, including cardiovascular mortality and morbidity, revascularisation, and non-traumatic amputation within 5 years. Patients and staff assessing outcomes were unaware of the practice's study group assignment. Analysis was done by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00237549.Findings Primary endpoint data were available for 3055 (99·9%) of 3057 screen-detected patients. The mean age was 60·3 (SD 6·9) years and the mean duration of follow-up was 5·3 (SD 1·6) years. Improvements in cardiovascular risk factors (HbA(1c) and cholesterol concentrations and blood pressure) were slightly but significantly better in the intensive treatment group. The incidence of first cardiovascular event was 7·2% (13·5 per 1000 person-years) in the intensive treatment group and 8·5% (15·9 per 1000 person-years) in the routine care group (hazard ratio 0·83, 95% CI 0·65-1·05), and of all-cause mortality 6·2% (11·6 per 1000 person-years) and 6·7% (12·5 per 1000 person-years; 0·91, 0·69-1·21), respectively.Interpretation An intervention to promote early intensive management of patients with type 2 diabetes was associated with a small, non-significant reduction in the incidence of cardiovascular events and death.Funding National Health Service Denmark, Danish Council for Strategic Research, Danish Research Foundation for General Practice, Danish Centre for Evaluation and Health Technology Assessment, Danish National Board of Health, Danish Medical Research Council, Aarhus University Research Foundation, Wellcome Trust, UK Medical Research Council, UK NIHR Health Technology Assessment Programme, UK National Health Service R&D, UK National Institute for Health Research, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, Novo Nordisk, Astra, Pfizer, GlaxoSmithKline, Servier, HemoCue, Merck.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ADDITION (Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care) trial showed that microvascular or macrovascular events were not significantly reduced after 5 or 10 years (17% and 13% reduction, respectively), while intervention only slightly improved HbA1c.364,365”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [365]
Experimental — accuracy not yet measuredIn the citing paper
“These positive effects were not observed in the clinical intervention trials of intensified, multifactorial treatment for T2DM in primary care and early in the disease trajectory.”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [365]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Research works printed but not linked: 2
- Rutten, 1999, Dutch College of General Practitioners. Practice guideline diabetes mellitus type 2, Huisarts Wetensch, 42, 67
- Rutten, 2006, Dutch Guidelines on Type 2 Diabetes Mellitus. Dutch College of General Practitioners, Huisarts Wetensch, 49, 137
Cited by
Sorted by citations
Items 201–300 of 462
Dasgupta, I., Zac‐Varghese, S., Chaudhry, K., McCafferty, K., Winocour, P. H., Chowdhury, T. A., Bellary, S., Goldet, G., Wahba, M. M., De, P., et al. (2024) · Diabetic Medicine · doi:10.1111/dme.15450 · Cited by 21
Diabetes: glycaemic control in type 2 (drug treatments).
Gorter, K. J., de Laar, F. A. V., Janssen, P. G. H., Houweling, S. T., & Rutten, G. E. H. M. (2012) · Europe PMC (PubMed Central) · Cited by 19
Self-citationShao, H., Yang, S., Stoecker, C., Fonseca, V. A., Hong, D., & Shi, L. (2019) · Value in Health · doi:10.1016/j.jval.2019.08.007 · Cited by 19
Chazova, I. E., Shestakova, M. V., Zhernakova, Y. V., Blinova, N. V., Маркова, Т. Н., Mazurina, N. V., Владиславович, Е. М., Tereshchenko, S. N., Жиров, И. В., Komarov, A. L., et al. (2021) · Eurasian heart journal · doi:10.38109/2225-1685-2021-2-6-61 · Cited by 19
Evidence Tips the Scale Toward Screening for Hyperglycemia
Narayan, K. M. V., & Gujral, U. P. (2015) · Diabetes Care · doi:10.2337/dc15-0856 · Cited by 18
Kuznetsov, L. V., Simmons, R. K., Sandbæk, A., & Maindal, H. T. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12570 · Cited by 18
Self-citationSerum neurofilament light chain – A potential biomarker for polyneuropathy in type 2 diabetes?
Määttä, L. L., Andersen, S. T., Parkner, T., Hviid, C. V. B., Bjerg, L., Kural, M. A., Charles, M., Søndergaard, E., Sandbæk, A., Tankişi, H., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110988 · Cited by 18
Self-citationLauritzen, T., Sandbæk, A., Carlsen, A. H., & Borch‐Johnsen, K. (2012) · Primary care diabetes · doi:10.1016/j.pcd.2012.04.005 · Cited by 18
Self-citationTsujimura, Y., Takahashi, Y., Ishizaki, T., Kuriyama, A., Miyazaki, K., Satoh, T., Ikeda, S., Kimura, S. H., & Nakayama, T. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.05.007 · Cited by 18
Palladino, R., Vamos, E. P., Chang, K., Khunti, K. K., Majeed, A., & Millett, C. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-58033-3 · Cited by 19
Self-citationMalkin, S. J. P., Hunt, B., Huisman, E. L., Grand, T. S., & Chubb, B. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108759 · Cited by 18
Gray, L. J., Barros, H., Raposo, L., Khunti, K., Davies, M. J., & Santos, A. C. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.01.003 · Cited by 18
Self-citationPedersen, M. B., Giraldi, A. G. E., Kristensen, E., Lauritzen, T., Sandbæk, A., & Charles, M. (2015) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813432.2014.1002295 · Cited by 18
Self-citationRisk of Statin-Induced Hypertransaminasemia
Villani, R., Navarese, E. P., Cavallone, F., Kubica, J., Bellanti, F., Facciorusso, A., Vendemiale, G., & Serviddio, G. (2019) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2019.01.003 · Cited by 17
Weight Change, Lifestyle, and Mortality in Patients With Type 2 Diabetes
Hu, J., Hu, Y., Hertzmark, E., Yuan, C., Liu, G., Stampfer, M. J., Rimm, E. B., Hu, F. B., Wang, M., & Sun, Q. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab800 · Cited by 18
Rydén, L., estable, G. D. T. D. L. S. E. D. C. S. D. Y. T. D. L. C. I., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H. P., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.10.015 · Cited by 20
Stuijver, D. J. F., Romualdi, E., van Zaane, B., Bax, L., Buller, H. R., Gerdes, V. E. A., & Squizzato, A. (2014) · Internal and Emergency Medicine · doi:10.1007/s11739-014-1168-2 · Cited by 17
Burggraaf, B., & Cabezas, M. C. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.04.017 · Cited by 17
Niwa, H., Takahashi, K., Dannoura, M., Omori, K., Miyoshi, A., Inada, T., & Miyoshi, H. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.45674 · Cited by 18
The Importance and Role of Multiple Risk Factor Control in Type 2 Diabetes
Nørgaard, C. H., Mosslemi, M., Lee, C. J., Torp-Pedersen, C. T., & Wong, N. D. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1123-y · Cited by 18
Simmons, R. K., Borch‐Johnsen, K., Lauritzen, T., Rutten, G. E. H. M., Sandbæk, A., van den Donk, M., Black, J. A., Tao, L., Wilson, E., Davies, M. J., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20640 · Cited by 20
Self-citationRodacki, M., Zajdenverg, L., Júnior, W. S. D. S., Giacaglia, L. R., Negrato, C. A., Cobas, R. A., de Almeida-Pititto, B., & Bertoluci, M. C. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01572-w · Cited by 19
den Ouden, H., Vos, R. C., Pieterse, A. H., & Rutten, G. E. H. M. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.02.006 · Cited by 16
Self-citationTackling the global diabetes burden: will screening help?
Engelgau, M. M., & Gregg, E. W. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61682-1 · Cited by 16
Klijs, B., Otto, S. J., Heine, R. J., van der Graaf, Y., Lous, J. J., & de Koning, H. J. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-671 · Cited by 17
Laxy, M., Wilson, E., Boothby, C. E., & Griffin, S. (2017) · Value in Health · doi:10.1016/j.jval.2017.05.018 · Cited by 12
Self-citationDiabetes in sub-Saharan Africa: from clinical care to health policy
Atun, R. A., Davies, J. I., Gale, E. A. M., Bärnighausen, T., Beran, D., & Kengne, A. P. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.13.10 · Cited by 17
Webb, D. R., Dales, J., Zaccardi, F., Hill, S., Moore, C., Farooqi, A. M., Griffin, S. J., Davies, M. J., & Khunti, K. K. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3111 · Cited by 16
Self-citationScreening of undiagnosed hyperglycaemia in the dental setting: The DiabetRisk study. A field trial
Montero, E., Matesanz, P., Nobili, A., Herrera-Pombo, J. L., Sanz, M., Guerrero, A., Bujaldón, A., & Herrera, D. (2020) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13408 · Cited by 16
Strelitz, J., Sharp, S. J., Khunti, K., Vos, R. C., Rutten, G. E. H. M., Webb, D. R., Witte, D. R., Sandbæk, A., Wareham, N. J., & Griffin, S. J. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14278 · Cited by 18
Self-citationMild depressive symptoms do not influence cognitive functioning in patients with type 2 diabetes
Koekkoek, P. S., Rutten, G. E. H. M., Ruis, C., Reijmer, Y. D., van den Berg, E., Gorter, K. J., Stehouwer, C. D. A., Dekker, J. M., Nijpels, G., Kappelle, L. J., et al. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.06.014 · Cited by 16
Self-citationPaul, C. L., Piterman, L., Shaw, J. E., Kirby, C. N., Fakes, K., Robinson, J. L., Thepwongsa, I., & Sanson‐Fisher, R. (2017) · Trials · doi:10.1186/s13063-017-1869-8 · Cited by 19
Safai, N., Carstensen, B., Vestergaard, H., & Ridderstråle, M. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019214 · Cited by 17
Cardiovascular Risk Factors in a Suburban Community in Nigeria
Dokunmu, T. M., Yakubu, O. F., Adebayo, A. H., Olasehinde, G. I., & Chinedu, S. N. (2018) · International Journal of Hypertension · doi:10.1155/2018/6898527 · Cited by 16
The economics of diabetes care: a global perspective
Williams, R. (2015) · doi:10.1002/9781118387658.ch77 · Cited by 16
Should we screen for type 2 diabetes? No
Goyder, E., Irwig, L., & Payne, N. (2012) · BMJ · doi:10.1136/bmj.e4516 · Cited by 14
Dutt, C., Salles, J. E. N., Joshi, S., Nair, T., Chowdhury, S., Mithal, A., Mohan, V., Kasliwal, R., Sharma, S., Tijssen, J. G. P., et al. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s333787 · Cited by 16
Potential Drug Combinations to Reduce Cardiovascular Disease Burden in Diabetes
Pillarisetti, S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.11.009 · Cited by 15
Kacha, G., HIGHTON, P. J., Funnell, M. P., Gillies, C., Onuwe, T., Kumar, N. S., Cos, X., Ceriello, A., Seidu, S., & Khunti, K. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113001 · Cited by 17
Self-citationUnderstanding the Type 2 Diabetes Mellitus and Cardiovascular Disease Risk Paradox
Green, J. B. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.05.2767 · Cited by 14
Barer, Y., Cohen, O., & Cukierman‐Yaffe, T. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13581 · Cited by 15
Gjelsvik, B., Tran, A. T. N., Berg, T. J., Bakke, Å., Mdala, I., Nøkleby, K., Cooper, J. G., Claudi, T., Løvaas, K. F., Thue, G., et al. (2019) · BJGP Open · doi:10.3399/bjgpopen18x101636 · Cited by 15
Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
Ahn, C. H., & Lim, S. K. (2019) · Journal of Stroke · doi:10.5853/jos.2019.00038 · Cited by 14
Shi, X., He, J., Lin, M., Liu, C., Yan, B., Song, H., Wang, C., Xiao, F., Huang, P., Wang, L., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.04.009 · Cited by 14
Malkin, S. J. P., Carvalho, D. M., Costa, C., Conde, V., & Hunt, B. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00801-4 · Cited by 16
Barakat, A., Williams, K. M., Prevost, A. T., Kinmonth, A. L., Wareham, N. J., Griffin, S. J., & Simmons, R. K. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03765.x · Cited by 14
Self-citationShi, C., Men, L., Yu, C., Yao, J., Bai, R., Yang, Y., Sun, L., Sun, G., Song, G., Zhang, Y., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.05.008 · Cited by 14
Malkin, S. J. P., Russel-Szymczyk, M., Psota, M., Hlavinkova, L., & Hunt, B. (2019) · Advances in Therapy · doi:10.1007/s12325-019-00965-y · Cited by 15
Black, J. A., Sharp, S., Wareham, N., Sandbæk, A., Rutten, G., Lauritzen, T., Khunti, K., Davies, M., Borch-Johnsen, K., Griffin, S., et al. (2014) · The British journal of general practice : the journal of the Royal College of General Practitioners · doi:10.3399/bjgp14x677833 · Cited by 14
Self-citationKawano, Y., Takemoto, M., Mito, T., Morisaki, H., Tanaka, A., Sakaki, Y., Matsuo, A., Abe, K., Hida, S., Mukae, K., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.008 · Cited by 13
Usman, M., Gillies, C., Khunti, K., & Davies, M. J. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.002 · Cited by 13
Self-citationMaindal, H. T., Carlsen, A. H., Lauritzen, T., Sandbæk, A., & Simmons, R. K. (2014) · Diabetic Medicine · doi:10.1111/dme.12440 · Cited by 13
Self-citationSiebenhofer, A., Paulitsch, M., Pregartner, G., Berghold, A., Jeitler, K., Muth, C., & Engler, J. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.10.010 · Cited by 13
Vidal, J., Malkin, S. J. P., Hunt, B., Martín, V., Hallén, N., & Ortega, F. J. M. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00751-7 · Cited by 14
Dambha-Miller, H., Day, A., Kinmonth, A. L., & Griffin, S. J. (2021) · Family Practice · doi:10.1093/fampra/cmaa086 · Cited by 12
Self-citationDambha‐Miller, H., Griffin, S. J., Kinmonth, A. L., & Burt, J. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x710945 · Cited by 12
Self-citationEvans, M., Berry, S., Malkin, S. J. P., Hunt, B., & Sharma, A. K. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01408-2 · Cited by 12
Bozorgmanesh, M., Hadaegh, F., Mohebi, R., Ghanbarian, A., Eskandari, F., & Azizi, F. (2013) · Blood Pressure · doi:10.3109/08037051.2013.769294 · Cited by 12
Kural, M. A., Andersen, S. T., Andersen, N. T., Andersen, H., Charles, M., Finnerup, N. B., Jensen, T. S., & Tankişi, H. (2018) · Muscle & Nerve · doi:10.1002/mus.26361 · Cited by 12
Johansen, P., Hunt, B., Iyer, N. N., Dang‐Tan, T., & Pollock, R. F. (2019) · Advances in Therapy · doi:10.1007/s12325-019-00915-8 · Cited by 12
Dalsgaard, E., Witte, D. R., Charles, M., Jørgensen, M. E., Lauritzen, T., & Sandbæk, A. (2019) · BMC Public Health · doi:10.1186/s12889-019-6549-z · Cited by 12
Self-citationShen, X., Zaorsky, N. G., Mishra, M. V., Foley, K. A., Hyslop, T., Hegarty, S., Pizzi, L. T., Dicker, A. P., & Showalter, T. N. (2011) · Future Oncology · doi:10.2217/fon.11.131 · Cited by 11
The societal impact of early intensified treatment in patients with type 2 diabetes mellitus
Tsotra, F., Kappel, M., Peristeris, P., Bader, G., Levi, E., Lister, N., Malhotra, A., & Ostwald, D. A. (2022) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2022-0110 · Cited by 11
Simmons, R. K., Carlsen, A. H., Griffin, S. J., Charles, M., Christiansen, J. S., Borch‐Johnsen, K., Sandbæk, A., & Lauritzen, T. (2014) · Diabetic Medicine · doi:10.1111/dme.12574 · Cited by 11
Self-citationGao, Y., Peterson, E. D., & Pagidipati, N. J. (2019) · Clinical Cardiology · doi:10.1002/clc.23252 · Cited by 11
Data-analytically derived flexible HbA1c thresholds for type 2 diabetes mellitus diagnostic
Stranieri, A., Yatsko, A., Jelinek, H. F., & Venkatraman, S. (2015) · Artificial Intelligence Research · doi:10.5430/air.v5n1p111 · Cited by 11
Stauffer, F., Viswanathan, B., Jean, M., Kinabo, P., & Bovet, P. (2016) · Journal of Laboratory Medicine · doi:10.1515/labmed-2015-0089 · Cited by 13
Ali, M. K., Singh, K., Kondal, D., Devarajan, R., Patel, S. A., Menon, V. U., Varthakavi, P. K., Vishwanathan, V., Dharmalingam, M., Bantwal, G., et al. (2024) · PLOS Medicine · doi:10.1371/journal.pmed.1004335 · Cited by 10
He, P., Deng, Y., Dong, S., Li, H., Liu, C., Ma, Y., Tang, C., & Zhang, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1364028 · Cited by 10
Ahern, A. L., Woolston, J., Wells, E. K., Sharp, S. J., Islam, N., Lawlor, E. R., Duschinsky, R., Hill, A. J., Doble, B., Wilson, E., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035020 · Cited by 10
Self-citationFeasibility Study of Advanced Cardiovascular Screening in Middle-Aged Patients with Diabetes
Lindholt, J. S., Frystyk, J., Hallas, J., Rasmussen, L. M., & Diederichsen, A. C. P. (2020) · Clinical Epidemiology · doi:10.2147/clep.s246636 · Cited by 10
Masood, M. Q., Singh, K., Kondal, D., Ali, M. K., Mawani, M., Devarajan, R., Menon, U. V., Varthakavi, P. K., Viswanathan, V., Dharmalingam, M., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108555 · Cited by 10
Shi, Q., Lin, Y., Fonseca, V. A., & Shi, L. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002396 · Cited by 10
Phung, T. L., Wu, O., Thavorncharoensap, M., Srinonprasert, V., Anothaisintawee, T., Thakkinstian, A., Phuong, N. K., & Chaikledkaew, U. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261231 · Cited by 10
New Insights in the Prevention and Early Management of Type 2 Diabetes
Lau, D. C. W. (2011) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(11)53002-3 · Cited by 10
Charles, M., Simmons, R. K., Williams, K. M., Roglić, G., Sharp, S. J., Kinmonth, A., Wareham, N. J., & Griffin, S. J. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x649070 · Cited by 10
Self-citationJiao, F., Wan, E. Y. F., Fung, C. S. C., Chan, A. K. C., McGhee, S. M., Kwok, R. L. P., & Lam, C. L. K. (2018) · Endocrine · doi:10.1007/s12020-018-1727-9 · Cited by 9
Baptista, L. C. P., Machado‐Rodrigues, A. M., & Martins, R. A. (2018) · Biology of Sport · doi:10.5114/biolsport.2018.78057 · Cited by 11
Camille, M., Nganou–Gnindjio, C. N., Azabji‐Kenfack, M., Mfeukeu‐Kuate, L., Dehayem, M. Y., Mbanya, J. C., & Sobngwi, E. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107875 · Cited by 10
Evans, M., Chubb, B., Malkin, S. J. P., Berry, S., Lawson, J., & Hunt, B. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14892 · Cited by 9
Dalsgaard, E., Vestergaard, M., Skriver, M. V., Borch‐Johnsen, K., Lauritzen, T., & Sandbæk, A. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2014.01.006 · Cited by 10
Self-citationHeianza, Y., Suzuki, A., Fujihara, K., Tanaka, S., Kodama, S., Hanyu, O., & Sone, H. (2014) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2014-204054 · Cited by 10
Black, J. A., Simmons, R. K., Boothby, C. E., Davies, M. J., Webb, D. R., Khunti, K. K., Long, G. H., & Griffin, S. J. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000075 · Cited by 10
Self-citationCosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Self-citationYovera-Aldana, M., Mezones‐Holguín, E., Agüero-Zamora, R., Damas-Casani, L. N., Uriol-Llanos, B., Espinoza‐Morales, F., Soto-Becerra, P., & Ticse, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299674 · Cited by 11
Jensen, T. M., Vistisen, D., Fleming, T. H., Nawroth, P. P., Jørgensen, M. E., Lauritzen, T., Sandbæk, A., & Witte, D. R. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0739-7 · Cited by 9
Self-citationGray, L. J., Davies, M. J., & Khunti, K. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2834-2_15 · Cited by 9
Self-citationEstlin, A. F. L., Ahern, A. L., Griffin, S. J., & Strelitz, J. (2021) · Diabetic Medicine · doi:10.1111/dme.14646 · Cited by 8
Self-citationHe, J., Xi, Y., Lam, H., Du, K., Chen, D., Dong, Z., & Xiao, J. (2023) · Journal of Diabetes Research · doi:10.1155/2023/8818502 · Cited by 8
Jansson, S. P. O., Andersson, D. K. G., & Svärdsudd, K. (2015) · Diabetic Medicine · doi:10.1111/dme.13019 · Cited by 8
Screening for diabetes: what do the results of the ADDITION trial mean for clinical practice?
Lauritzen, T., Borch‐Johnsen, K., Davies, M. J., Khunti, K., Rutten, G. E. H. M., Sandbæk, A., Simmons, R. K., van den Donk, M., Wareham, N. J., & Griffin, S. J. (2013) · Diabetes Management · doi:10.2217/dmt.13.40 · Cited by 7
Self-citationEASD, E. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0289 · Cited by 9
Savory, L. A., Griffin, S. J., Williams, K. M., Prevost, A. T., Kinmonth, A. L., Wareham, N. J., & Simmons, R. K. (2013) · Diabetic Medicine · doi:10.1111/dme.12316 · Cited by 8
Self-citationScreening for Diabetes and Prediabetes
Gray, L. J., Willis, A. M., Webb, D. R., Davies, M. J., & Khunti, K. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_12 · Cited by 9
Self-citationNomoto, H., Kimachi, K., Miyoshi, H., Kameda, H., Cho, K. Y., Nakamura, A., Nagai, S., Kondo, T., & Atsumi, T. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0546 · Cited by 9
Silva, C. C., Presseau, J., van Allen, Z., Dinsmore, J. G., Schenk, P. M., Moreto, M., & Marques, M. M. (2024) · Health Psychology Review · doi:10.1080/17437199.2024.2413871 · Cited by 11
Inference on win ratio for cluster-randomized semi-competing risk data
Zhang, D., & Jeong, J. (2021) · Japanese Journal of Statistics and Data Science · doi:10.1007/s42081-021-00131-1 · Cited by 8
It’s NOT FAIR! Or is it? The promise and the tyranny of evidence-based performance assessment
Bogdan‐Lovis, E., Fleck, L. M., & Barry, H. C. (2012) · Metamedicine · doi:10.1007/s11017-012-9228-y · Cited by 8
Glycated hemoglobin A1c(HbA1c) and diabetes: a new era?
Katsiki, N., Παπάνας, Ν., Mikhailidis, D. P., & Fonseca, V. A. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.618179 · Cited by 8
Does the evidence support population-wide screening for type 2 diabetes? No
Shaw, J. E. (2017) · Diabetologia · doi:10.1007/s00125-017-4393-1 · Cited by 7
Metadata
- Authors
- Griffin, S. J., Borch-Johnsen, K., Davies, M. J., Khunti, K., Rutten, G. E., Sandbæk, A., Sharp, S. J., Simmons, R. K., van den Donk, M., Wareham, N. J., & Lauritzen, T.
- Affiliations
- University of Cambridge (GB)
- University of Leicester (GB)
- University Medical Center Utrecht (NL)
- Aarhus University (DK)
- Wellcome/MRC Institute of Metabolic Science (GB)
- Corresponding author
- Griffin, Simon J
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 378
- Issue
- 9786
- Pages
- 156-167
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC3136726
- OpenAlex
- W2146392529
- Cited by
- 462
- References
- 43
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 17 · 2023: 14 · 2022: 21 · 2021: 18 · 2020: 35 · 2019: 31 · 2018: 30 · 2017: 38 · 2016: 30 · 2015: 49 · 2014: 46 · 2013: 46 · 2012: 56
- FWCI
- 50.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- The Lancet (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Funders
- the Wellcome Trust (G061895)
- the Medical Research Council (G0001164)
- the NIHR Health Technology Assessment Programme (08/116/300)
- National Health Service R&D support funding (RP-PG-0606-1259)
- Department of Health and ad hoc Support Sciences, the NIHR Health Technology Assessment Programme (08/116/300)
- the Department of Health NIHR Programme Grant funding scheme (RP-PG-0606-1272)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, cardiovascular risk management, diabetes screening, cardiovascular events, cardiovascular mortality, all-cause mortality, revascularization, non-traumatic amputation, HbA1c, blood pressure, cholesterol, general practice, primary prevention, secondary prevention, risk stratification
- MeSH terms
- Aged, Denmark, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, United Kingdom, Humans, Hypoglycemic Agents, Male, Mass Screening, Middle Aged, Netherlands, Risk Factors, Cluster Analysis, Outcome Assessment, Health Care, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
